Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: May 31, 2020
Date Accepted: Aug 3, 2020
Date Submitted to PubMed: Aug 4, 2020

The final, peer-reviewed published version of this preprint can be found here:

What Factors Increase the Risk of Complications in SARS-CoV-2–Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization

Yanover C, Mizrahi B, Kalkstein N, Marcus K, Akiva P, Barer Y, Shalev V, Chodick G

What Factors Increase the Risk of Complications in SARS-CoV-2–Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization

JMIR Public Health Surveill 2020;6(3):e20872

DOI: 10.2196/20872

PMID: 32750009

PMCID: 7451109

What factors increase the risk of complications in SARS-Cov-2 infected patients? A cohort study in a nationwide Israeli health organization

  • Chen Yanover; 
  • Barak Mizrahi; 
  • Nir Kalkstein; 
  • Karni Marcus; 
  • Pinchas Akiva; 
  • Yael Barer; 
  • Varda Shalev; 
  • Gabriel Chodick

ABSTRACT

Background:

Reliably identifying patients at increased risk for coronavirus disease 2019 (COVID-19) complications could guide clinical decisions, public health policies, and preparedness efforts. Multiple studies have attempted to characterize at-risk patients, using various data sources and methodologies. Most of these studies, however, explored condition-specific patient cohorts (e.g., hospitalized patients) or had limited access to patients’ medical history; thus, investigating related questions and, potentially, obtaining biased results.

Objective:

To identify factors associated with COVID-19 complications from the complete medical records of a nationally representative SARS-CoV-2 infected cohort.

Methods:

We studied the cohort of all SARS-CoV-2 positive individuals, confirmed by polymerase chain reaction testing of either nasopharyngeal or saliva samples, in a nationwide health organization (covering 2.3 million individuals) and identified those who suffered from serious complications (that is, experienced moderate or severe symptoms of COVID-19, admitted to intensive care unit or died). We then compared the prevalence of pre-existing conditions, extracted from electronic health records, between complicated and non-complicated COVID-19 patient cohorts to identify the conditions that significantly increase the risk of disease complications, in various age and sex strata.

Results:

Of the 4,353 SARS-CoV-2 positive individuals, 173 (4%) patients suffered from COVID-19 complications (all above the age of 18 years). Our analysis suggests that cardiovascular and kidney diseases, obesity, and hypertension are significant risk factors for COVID-19 complications, as previously reported. Interestingly, it also indicates that depression (e.g., odds ratio, OR, for males 65 years or older: 2.94, 95% confidence intervals [1.55, 5.58]; P = .014) as well as cognitive and neurological disorder (e.g., OR for individuals ≥ 65 years old: 2.65 [1.69, 4.17]; P < .001) are significant risk factors; and that smoking and background of respiratory diseases do not significantly increase the risk of complications.

Conclusions:

Adjusting existing risk definitions following these observations may improve their accuracy and impact the global pandemic containment and recovery efforts.


 Citation

Please cite as:

Yanover C, Mizrahi B, Kalkstein N, Marcus K, Akiva P, Barer Y, Shalev V, Chodick G

What Factors Increase the Risk of Complications in SARS-CoV-2–Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization

JMIR Public Health Surveill 2020;6(3):e20872

DOI: 10.2196/20872

PMID: 32750009

PMCID: 7451109

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement